Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause End stage renal disease? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of End stage renal disease have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.0% of all adverse event reports for GEMCITABINE.

11
Reports of End stage renal disease with GEMCITABINE
0.0%
of all GEMCITABINE reports
0
Deaths
5
Hospitalizations

How Dangerous Is End stage renal disease From GEMCITABINE?

Of the 11 reports, 5 (45.5%) required hospitalization, and 3 (27.3%) were considered life-threatening.

Is End stage renal disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause End stage renal disease?

OMEPRAZOLE (10,356) ESOMEPRAZOLE (10,231) LANSOPRAZOLE (9,734) PANTOPRAZOLE (8,523) DEXLANSOPRAZOLE (4,800) RABEPRAZOLE (1,295) EMTRICITABINE\TENOFOVIR DISOPROXIL (721) TENOFOVIR DISOPROXIL (558) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (462) TACROLIMUS (361)

Which GEMCITABINE Alternatives Have Lower End stage renal disease Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All End stage renal disease Reports All Drugs Causing End stage renal disease GEMCITABINE Demographics